In this study, we present evidence to support that among 15 different ginsenosides, G-F1, a deglycosylated metabolite of G-Rg1, significantly potentiates NK cell functions, such as cytotoxicity and IFN-γ production, and thereby enhances the susceptibility of diverse cancer cells to NK cells. The gene discussed is IFNG; the disease is cancer.